Tempus
Contact SalesAI-powered precision medicine & genomic testing platform.
By Tanmay Verma, Founder · Last verified 26 May 2026
4.3k views
Added 4/3/2026
80/100Safe BetAI-powered precision medicine & genomic testing platform.
By Tanmay Verma, Founder · Last verified 26 May 2026
Affiliate disclosure: We earn a commission when you use our links. Editorial picks are independent. How we choose.
Tempus stands out for its AI-first approach in precision medicine, embedding machine learning directly into genomic testing and clinical workflows. However, enterprise-only pricing (not publicly disclosed) and platform complexity limit accessibility for smaller practices. It's a strong contender for large oncology centers seeking integrated genomics and AI analytics, but cost-sensitive buyers should compare against offerings from Foundation Medicine or Caris Life Sciences.
Last verified: May 2026
Tempus is a serious player in precision oncology, differentiating itself by weaving AI throughout its genomic testing and clinical decision support. The platform's foundation models aim to surface treatment insights and trial matches directly from patient data, which can reduce time-to-decision for oncologists. Its strengths lie in scale—large healthcare systems can integrate Tempus across multiple sites, leveraging de-identified data for research and real-world evidence generation. However, the platform's complexity demands dedicated IT and clinical informatics support, and the lack of transparent pricing makes it difficult for smaller clinics to evaluate. Tempus is actively expanding beyond oncology into cardiology and neurology (e.g., Tempus PRO). For organizations already invested in precision medicine and willing to commit to enterprise integration, Tempus offers a comprehensive AI-driven solution. For those seeking a simpler, lower-cost genomic testing option, alternatives like Guardant Health or Natera may be more accessible.
Skip Tempus if Skip Tempus if you are a small clinic without IT support or need transparent, upfront pricing.
How likely is Tempus to still be operational in 12 months? Based on 6 signals including funding, development activity, and platform risk.
Tempus is an AI-powered precision medicine platform that analyzes clinical and genomic data to help providers personalize cancer treatment. It offers AI-enabled genomic testing, foundation models for clinical deployment, and data-driven decision support integrated into oncology workflows. The platform serves large healthcare organizations seeking to embed AI at scale, combining advanced analytics with clinical expertise. Compared to traditional genomic services, Tempus embeds AI directly into testing and analysis, offering actionable insights for targeted therapy, trial matching, and drug discovery.
Tell us what you want to build — we'll match the AI tools that fit your goal, budget & existing stack.
Concrete scenarios for the personas Tempus actually fits — and what changes day-one when you adopt it.
You order a Tempus genomic test for a new lung cancer patient. The AI analyzes the tumor's DNA and RNA, cross-references with clinical databases, and returns a report within days highlighting targeted therapy options and relevant clinical trials.
Outcome: You can make a data-driven treatment decision faster, potentially matching the patient to a targeted therapy or trial they otherwise might have missed.
You use Tempus' de-identified data access and real-world evidence tools to analyze treatment patterns and outcomes across a large patient cohort, accelerating protocol design for a new oncology drug.
Outcome: You generate robust real-world evidence to support trial design and regulatory submissions, reducing time and cost.
You oversee integration of Tempus' AI models into the existing EHR and clinical workflow. Tempus provides APIs and FHIR-based data pipelines to connect genomic results with patient records.
Outcome: Clinicians see AI-generated insights directly within their existing systems, minimizing disruption and improving adoption.
Pricing is enterprise-only and not publicly disclosed, making it inaccessible for small practices. The platform's complexity may require dedicated IT support for integration. It is primarily focused on oncology, though expanding into other areas. Direct-to-consumer access is not available.
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
For each published Tempus tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.
Clinical
Custom
Ideal for
Large oncology centers seeking integrated genomic profiling with AI-driven treatment insights and clinical trial matching.
What this tier adds
Starting tier focused on direct patient care — includes genomic profiling, AI treatment insights, and clinical matching.
Research
Custom
Ideal for
Pharma and academic researchers needing de-identified real-world data and AI models for drug discovery and evidence generation.
What this tier adds
Adds de-identified data access, AI models, and real-world evidence tools for research purposes.
The company stage and team size where Tempus's pricing actually pencils out — and where peers do it cheaper.
Tempus uses opaque enterprise pricing, typical for large-scale precision medicine platforms. For smaller practices, Guardant Health or Natera offer simpler, published pricing. Tempus is best suited for health systems with dedicated budgets for AI-driven genomics.
How long it actually takes to get something useful out of Tempus — broken out by persona, not the marketing-page minute.
For a large oncology center, initial integration (EHR connection, genomic testing logistics, AI model deployment) typically takes 3–6 months. IT support and informatics staff are required. For Tempus PRO (AI-assisted notetaking), setup is faster—weeks rather than months.
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
Pricing, brand, ownership, or deprecation changes worth knowing before you commit. Most-recent first.
Used Tempus? Help shape our editorial sentiment research.
© 2026 RightAIChoice. All rights reserved.
Built for the AI community.
Last calculated: May 2026
Durable execution platform for crash-safe AI agents and workflows.
